Insider · CIK 0001792061

DiRocco Derek

Reports to the SEC for 6 companies · WATERTOWN, MA

sec.gov

Transactions

Companies

Filings

CIK

0001792061

Forms 4 and 5

Insider transactions

33 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-17	ACRVAcrivon Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20.3K sh	—	—	20,275
2026-05-18	ACRVAcrivon Therapeutics, Inc.A Award	Director	AAward	+9,366 sh	—	—	9,366
2026-02-19	MLYSMineralys Therapeutics, Inc. · Stock OptionA Award	Director	AAward	+8,300 sh	—	—	8,300
2026-02-19	MLYSMineralys Therapeutics, Inc.A Award	Director	AAward	+6,200 sh	—	—	6,200
2025-10-30	ETNB89bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.5K sh	—	—	0
2025-10-30	ETNB89bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,000 sh	—	—	0
2025-10-30	ETNB89bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,000 sh	—	—	0
2025-10-30	ETNB89bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2025-10-30	ETNB89bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−27.4K sh	—	—	0
2025-10-30	ETNB89bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−45.2K sh	—	—	0
2025-10-30	ETNB89bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−56.4K sh	—	—	0
2025-06-13	ACRVAcrivon Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20.3K sh	—	—	20,275
2025-02-13	MLYSMineralys Therapeutics, Inc. · Stock OptionA Award	Director	AAward	+32.9K sh	—	—	32,900
2025-02-03	ETNB89bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+56.4K sh	—	—	56,400
2024-06-20	ACRVAcrivon Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20.3K sh	—	—	20,275
2024-05-24	HOWLWerewolf Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+17.5K sh	—	—	17,500
2024-05-22	MLYSMineralys Therapeutics, Inc. · Stock OptionA Award	Director	AAward	+22K sh	—	—	22,000
2024-02-01	ETNB89bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+45.2K sh	—	—	45,150
2023-06-21	HOWLWerewolf Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+13.2K sh	—	—	13,200
2023-06-13	iTeos Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+22.4K sh	—	—	22,383
2023-02-09	MLYSMineralys Therapeutics, Inc. · Common StockA Award	Director	AAward	+44K sh	—	—	44,000
2023-02-09	ETNB89bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+27.4K sh	—	—	27,400
2022-11-14	ACRVAcrivon Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+35.2K sh	—	—	35,235
2022-06-09	iTeos Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+17.5K sh	—	—	17,538
2022-06-01	HOWLWerewolf Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+11.6K sh	—	—	11,600
2022-05-16	ETNB89bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2021-06-17	iTeos Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+16.6K sh	—	—	0
2021-04-30	HOWLWerewolf Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+23.2K sh	—	—	23,200
2021-04-15	ETNB89bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2020-07-23	iTeos Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+16.6K sh	—	—	0
2020-07-23	iTeos Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+16.6K sh	—	—	0
2020-06-22	ETNB89bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+7,000 sh	—	—	7,000
2020-04-05	ETNB89bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+7,000 sh	—	—	7,000

Recent filings

Accepted (ET)
Jun 224
DiRocco Derek0000905148-26-003033
SEC(opens sec.gov)
May 204
DiRocco Derek0000905148-26-002558
SEC(opens sec.gov)
Feb 204
DiRocco Derek0001933414-26-000039
SEC(opens sec.gov)
Oct 304
DiRocco Derek0001193125-25-259038
SEC(opens sec.gov)
Jun 174
DiRocco Derek0000905148-25-002177
SEC(opens sec.gov)
Feb 244
DiRocco Derek0001933414-25-000016
SEC(opens sec.gov)
Feb 54
DiRocco Derek0000950170-25-014436
SEC(opens sec.gov)
Jun 244
DiRocco Derek0000905148-24-001775
SEC(opens sec.gov)
May 244
DiRocco Derek0000950170-24-064848
SEC(opens sec.gov)
May 234
DiRocco Derek0001933414-24-000023
SEC(opens sec.gov)
Feb 54
DiRocco Derek0000950170-24-011476
SEC(opens sec.gov)
Jun 234
DiRocco Derek0000899243-23-016379
SEC(opens sec.gov)
Jun 154
DiRocco Derek0001209191-23-037588
SEC(opens sec.gov)

Companies

Address

C/O ACRIVON THERAPEUTICS, INC. 480 ARSENAL WAY, SUITE 100

WATERTOWN, MA, 02472